Skip to content

Criteria for Return-to-Work after hematopoietic cell transplantation - Expert Survey

Criteria for Return-to-Work after hematopoietic cell transplantation - Expert Survey - RTW - allo

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00035659
Enrollment
20
Registered
2025-03-10
Start date
2025-04-14
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients after stem cell transplantion

Interventions

Group 1: Possible basic criteria for a return to work and experiences with previous return to work procedures should be reported once by experts from their own experience and perspective

Sponsors

Klinik für Onkologie, Hämatologie und Stammzelltransplantation, Medizinische Fakultät, RWTH Uniklinik Aachen
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Experts in stem cell transplant centers (‘ABCD Network’; Aachen, Cologne, Bonn, Düsseldorf)

Exclusion criteria

Exclusion criteria: Non-experts

Design outcomes

Primary

MeasureTime frame
Documentation of the current handling and ,if applicable, criteria from an expert perspective on return to work in patients after allogeneic stem cell transplantation

Secondary

MeasureTime frame
further comments (freetext analysis)

Countries

Germany

Contacts

Public ContactMartina Crysandt

Klinik für Onkologie, Hämatologie und Stammzelltransplantation, Medizinische Fakultät, RWTH Uniklinik Aachen

mcrysandt@ukaachen.de+49241800

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026